Marvisi, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.355
NA - Nord America 3.323
EU - Europa 1.857
SA - Sud America 439
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 67
OC - Oceania 14
Totale 9.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.216
SG - Singapore 1.095
CN - Cina 983
IT - Italia 653
HK - Hong Kong 354
BR - Brasile 347
VN - Vietnam 311
DE - Germania 218
GB - Regno Unito 213
FI - Finlandia 193
BD - Bangladesh 183
KR - Corea 157
RU - Federazione Russa 124
SE - Svezia 100
FR - Francia 95
CA - Canada 60
NL - Olanda 54
IN - India 45
ID - Indonesia 44
IE - Irlanda 38
AR - Argentina 34
AT - Austria 31
MX - Messico 30
IQ - Iraq 29
JP - Giappone 27
LT - Lituania 22
TR - Turchia 21
MA - Marocco 20
PL - Polonia 20
BG - Bulgaria 19
UA - Ucraina 16
CL - Cile 14
AU - Australia 13
PK - Pakistan 13
KW - Kuwait 12
PT - Portogallo 12
ZA - Sudafrica 12
EC - Ecuador 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
ES - Italia 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
PE - Perù 8
TW - Taiwan 8
CZ - Repubblica Ceca 7
PH - Filippine 7
VE - Venezuela 7
CO - Colombia 6
IL - Israele 6
KE - Kenya 6
AZ - Azerbaigian 5
GR - Grecia 5
MY - Malesia 5
AL - Albania 4
EG - Egitto 4
LB - Libano 4
PY - Paraguay 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BE - Belgio 3
BS - Bahamas 3
CH - Svizzera 3
CR - Costa Rica 3
KG - Kirghizistan 3
LV - Lettonia 3
MT - Malta 3
RS - Serbia 3
AM - Armenia 2
ET - Etiopia 2
GY - Guiana 2
KZ - Kazakistan 2
NI - Nicaragua 2
SN - Senegal 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KY - Cayman, isole 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
Totale 9.044
Salva come PNG Salva come JPEG
Città #
Santa Clara 708
Singapore 677
Hefei 501
Ashburn 382
San Jose 353
Hong Kong 350
Helsinki 168
Seoul 155
London 132
Munich 129
Beijing 121
Council Bluffs 113
Ho Chi Minh City 104
Chandler 101
Milan 96
Los Angeles 92
The Dalles 88
Fairfield 81
Hanoi 69
Nyköping 64
Dallas 63
New York 59
Chicago 55
Moscow 50
Lauterbourg 49
Buffalo 38
Dublin 37
Bologna 36
Rome 36
Jakarta 34
São Paulo 33
Seattle 32
Shanghai 29
Kent 28
Houston 27
Salt Lake City 27
Boardman 26
Cambridge 26
Nuremberg 25
Wilmington 25
San Diego 23
Woodbridge 23
Frankfurt am Main 22
Atlanta 18
Modena 18
Naples 18
Orem 18
Haiphong 17
Portsmouth 17
Redondo Beach 17
Rio de Janeiro 17
Tokyo 17
Amsterdam 15
Princeton 15
Toronto 15
Bremen 13
Florence 13
Lappeenranta 13
Vienna 13
Kuwait City 12
Tampa 12
Turin 12
Brooklyn 11
Columbus 11
Da Nang 11
Elk Grove Village 11
Montreal 11
Sofia 11
Denver 10
Mexico City 10
Reggio Emilia 10
Ankara 9
Manchester 9
Melbourne 9
San Francisco 9
Santiago 9
Tashkent 9
Turku 9
Warsaw 9
Ann Arbor 8
Baghdad 8
Chennai 8
Des Moines 8
Ksawerów 8
Lancaster 8
North Bergen 8
Padova 8
Parma 8
Brasília 7
Campinas 7
Casablanca 7
Curitiba 7
Guangzhou 7
Mumbai 7
Palermo 7
Thái Bình 7
Biên Hòa 6
Boston 6
Brescia 6
Cagliari 6
Totale 5.897
Salva come PNG Salva come JPEG
Nome #
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 338
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 314
EULAR guidelines on ANCA-associated vasculitis in the real life 272
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 237
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 224
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 215
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 207
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 201
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 200
Chronic periaortitis presenting with isolated pulmonary artery involvement: description of two cases 199
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 196
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy 190
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 190
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 189
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 181
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 179
The role of sacro-iliac joint magnetic resonance imaging in the diagnosis of axial spondyloarthritis: focus on differential diagnosis in women 176
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 172
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 171
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 168
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 165
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 164
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 162
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 159
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 159
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 157
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 156
Development of the Takayasu Arteritis Integrated Disease Activity Index 154
What to Know About Biopsy Sampling and Pathology in Vasculitis? 153
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm? 153
Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases 149
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 146
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 145
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 144
The management of large vessel vasculitides 142
Eosinophilic giant cell arteritis: A different subset of disease? 141
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 140
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 137
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 137
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 133
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 132
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 130
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 129
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases 128
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 123
Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply 121
Comparing treatment options for large vessel vasculitis 117
Reply 116
Systemic vasculitis: one year in review 2024 106
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease 104
Vasculitis, fibromuscular dysplasia or hereditary aneurysms? 103
Manifestations of Skull Base IgG4‐Related Disease: A Multi‐Institutional Study 102
Reply to Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al 94
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 92
The geographic and clinical clusters of Behçet’s syndrome 89
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 73
Hypereosinophilia and eosinophilic arterial aneurysm: not only eosinophilic granulomatosis with polyangiitis 67
Utilità clinica dell'imaging nell'arterite gigantocellulare 26
The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study 22
Is immunotherapy safe and effective in patients with VEXAS syndrome? 20
Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis 19
Totale 9.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022246 0 24 19 8 11 23 10 13 23 19 46 50
2022/2023483 35 47 28 20 69 51 33 52 60 22 38 28
2023/2024499 14 28 13 62 47 59 65 54 17 33 55 52
2024/20252.752 45 22 89 170 518 449 281 89 327 146 334 282
2025/20264.792 415 260 444 523 543 251 612 193 497 370 378 306
2026/2027195 172 23 0 0 0 0 0 0 0 0 0 0
Totale 9.128